Viewing Study NCT03439657


Ignite Creation Date: 2025-12-24 @ 6:48 PM
Ignite Modification Date: 2026-01-03 @ 11:07 PM
Study NCT ID: NCT03439657
Status: COMPLETED
Last Update Posted: 2022-01-11
First Post: 2018-02-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and Older
Sponsor: GlaxoSmithKline
Organization: